Friday, 29 March 2024
Affimed Therapeutics B.V.
NASDAQ : AFMD
1.520 14 Oct 22 00:00 | Change: 0.04 | Open: 1.520 | High: 1.570 | Ask: 0.000 | Volume: 1,504,900 |
Change(%): 2.56 | Prev: 1.560 | Low: 1.500 | Bid: 0.000 | Avg vol: 0 |
02:52 | 19/3/18
Frisco Fastball
Analysts expect Affimed N.V. (NASDAQ:AFMD) to report $-0.19 EPS on March, 29.They anticipate $0.02 EPS change or 11.76 % from last quarter's $-0.17 EPS.
more»
03:03 | 18/3/18
NMSU H?r?ld
The stock of Affimed N.V. (NASDAQ:AFMD) registered a decrease of 2.13% in short interest. AFMD's total short interest was 308,200 shares in March as published by FINRA.
more»
This is a real time view of the critical technical pivot points for Affimed N.V. (NASDAQ:AFMD) . The technical pivot points we look at all surround the stock price movement from the last 10-trading days through the last year.
more»
01:33 | 16/3/18
Danvers Record
Affimed N.V. (NasdaqGM:AFMD) has an ERP5 rank of 18365. The ERP5 Rank is an investment tool that analysts use to discover undervalued companies.
more»
20:52 | 15/3/18
PharmiWeb.com
Heidelberg, Germany, March 15, 2018 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, announced today the presentation of preclinical data for the ...
more»
There are currently no comments on this topic.
Be the first person to Add a Comment...
You must be a registered user to post a comment: REGISTER NOW
If you are already registered, please LOGIN NOW
|
Code | Last | Change |
COMP | 10,321 | 328 | | 3.08% |
DJI | 29,635 | 404 | | 1.34% |
SP500 | 3,583 | 87 | | 2.37% |
DAX | 12,438 | 82 | | 0.67% |
FTSE | 7,488 | 5 | | 0.07% |
NI225 | 22,420 | 408 | | 1.86% |
TWI | 67.27 | 0.00 | | 0.00% |